Classification Nuance. The OpenFDA dataset, which draws from the Structured Product Labeling (SPL) files, often includes multiple classification fields, and the specific string "Phosphate Binder [EPC]" may only be assigned to a single product. The other drugs are likely classified using: More Specific Classes: Many of those drugs (like sevelamer, ferric citrate, etc.) may be classified by their specific mechanism or chemical group, which also acts as a phosphate binder. Example: A drug might be classified as "Iron-Containing Compound [EPC]" or "Aluminum-Containing Compound [EPC]" instead of the more general "Phosphate Binder [EPC]". Different Classification Fields: The NDC data contains several classification fields. You might be checking the Established Pharmacological Class (pharm_class_epc), but the other drugs might be listed under: Mechanism of Action (pharm_class_moa), Physiological Effect (pharm_class_pe)
  Home  

Enter a class name or drug name above to search the database.

Neonatal Fc Receptor Blocker [EPC]

NDC Number Brand Name Generic Name Manufacturer Dosage Form DEA Sch. Marketing Start Date
50474-980 RYSTIGGO ROZANOLIXIZUMAB UCB, Inc. INJECTION, SOLUTION 2023-06-26
50474-981 RYSTIGGO ROZANOLIXIZUMAB UCB, Inc. INJECTION, SOLUTION 2024-06-14
50474-982 RYSTIGGO ROZANOLIXIZUMAB UCB, Inc. INJECTION, SOLUTION 2024-06-14
50474-983 RYSTIGGO ROZANOLIXIZUMAB UCB, Inc. INJECTION, SOLUTION 2024-06-14
73475-1221 VYVGART Hytrulo efgartigimod alfa and hyaluronidase (human recombinant) argenx US INJECTION, SOLUTION 2025-04-10
73475-3041 VYVGART EFGARTIGIMOD ALFA argenx US INJECTION 2021-12-17
73475-3102 VYVGART Hytrulo efgartigimod alfa and hyaluronidase (human recombinant) argenx US INJECTION, SOLUTION 2023-06-20



 [EPC] Established Pharmacological Classification 

Loading full table content...